Disclosure Of Fair Value Measurement [Text Block]

ABIONYX Pharma - Filing #2821124

Concept As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
10 288 EUR
10 249 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
176 730 EUR
1 232 EUR
30,000 EUR
39,000 EUR
11 797 EUR
170 322 EUR
6 629 EUR
11 699 EUR
25,000 EUR
92,000 EUR
168 621 EUR
6 666 EUR
174 818 EUR
1 097 EUR
11 601 EUR
25,000 EUR
947,000 EUR
167 832 EUR
176 595 EUR
3 838 EUR
78,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.